Conference - San Diego, CA, United States
IBC's Inaugural Commercialization of Cell, Gene & Immunotherapies will be held December 11-12, 2014 in San Diego, CA.
This new event will cover the exciting progress to accelerate the translation of commercially viable cell, gene and immunotherapies through the implementation of novel bioprocessing tools and technologies.
Capitalize on the Momentum being Gained from Technical Innovations That are Essential in Developing:
*Clear Engineering Paths to Overcome CMC Issues
*DOE and QbD Approaches with Functionally Closed Systems
*Scalable Bioreactor-Based Culture Platforms to Reduce Cost of Goods
*Custom Automated Processes to Address Large Scale Manufacturing Challenges
*GMP Manufacturing Processes for Clinical Grade HIV-1 Based Lentiviral Vectors
*Clinical Applications of Versatile CRISPR-Cas Systems
*Robust and Reliable Methods for Characterization, Comparability and Release Testing
*DOE and QbD Approaches with Functionally Closed Systems
*Scalable Bioreactor-Based Culture Platforms to Reduce Cost of Goods
*Custom Automated Processes to Address Large Scale Manufacturing Challenges
*GMP Manufacturing Processes for Clinical Grade HIV-1 Based Lentiviral Vectors
*Clinical Applications of Versatile CRISPR-Cas Systems
*Robust and Reliable Methods for Characterization, Comparability and Release Testing
- Organization: IBC Life Sciences
Thu, Dec 11, 2014 - Fri, Dec 12, 2014
Andaz San Diego
600 F Street, San Diego, CA 92101, San Diego, United States
-
If you'd like to ask a question or post a comment about this talk please do so below.This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
